ArticleScientific reports2026
Effects of Multifrequency Electromagnetic Pulses on tumor growth in immunocompetent mice.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
We previously established that a Multifrequency Electromagnetic Pulse (MEMP) treatment selectively eradicates tumorigenic cells in vitro. Here we evaluate the effect of two different systemic MEMP treatment regimens (30 Hz, > 2T) on syngeneic MC38 colon adenocarcinoma subcutaneously engrafted in C57BL/6 mice. Tumor development was monitored by bioluminescence imaging, and excised tissues were evaluated for immune-cell infiltration (CD4, CD8, and CD68), oxidative stress (HO-1, MDA), and DNA damage (γH2AX) markers by immunohistochemistry. The MEMP regimes consistently and significantly slowed tumor progression and extended animal survival, with no detectable adverse effects on welfare. Histopathology revealed in treated tumors broader necrotic regions, signals of oxidative stress, and γH2AX staining showing limited yet evident DNA damage. While the number of intratumor CD4 and CD8 T-cell-counts remained stable, an apparent increase in the number CD68+ macrophages was noticed in the tumors of treated mice, suggesting that MEMP may enhance the penetration of immune effectors cells into the xenografted tumors, a preliminary evidence deserving further research. Further, MEMP achieved complete tumor regression in a small subset of animals, (n = 2), which mounted a robust resistance to a subsequent tumor re-challenge. Collectively, our findings indicate that systemic MEMP can alter tumor dynamics and immune features in pre-clinical animal models, offering a practical framework to study tumor–immune interactions at the organismal level under controlled physical-field conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.